FMT
GILD icon

First Mercantile Trust’s Gilead Sciences GILD Stock Holding History

First Mercantile Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$155K Buy
+2,219
New +$156K 0.02% 501
2020
Q4 		– Sell
-4,507
Closed -$266K – 869
2020
Q3 		$266K Sell
4,507
-653
-13% -$45.3K 0.03% 299
2020
Q2 		$397K Buy
5,160
+1,040
+25% +$79.7K 0.05% 218
2020
Q1 		$308K Sell
4,120
-172
-4% -$11.9K 0.05% 234
2019
Q4 		$279K Buy
4,292
+2,090
+95% +$136K 0.03% 354
2019
Q3 		$140K Sell
2,202
-4
-0.2% -$261 0.01% 599
2019
Q2 		$149K Buy
2,206
+203
+10% +$13.4K 0.02% 539
2019
Q1 		$130K Sell
2,003
-2,964
-60% -$197K 0.03% 587
2018
Q4 		$311K Buy
4,967
+1,656
+50% +$116K 0.08% 300
2018
Q3 		$256K Sell
3,311
-219
-6% -$16.5K 0.05% 432
2018
Q2 		$250K Buy
3,530
+10
+0.3% +$706 0.05% 439
2018
Q1 		$265K Sell
3,520
-25,230
-88% -$2.01M 0.06% 409
2017
Q4 		$2.06M Sell
28,750
-4,643
-14% -$353K 0.4% 50
2017
Q3 		$2.71M Sell
33,393
-1,856
-5% -$142K 0.49% 43
2017
Q2 		$2.5M Sell
35,249
-4,884
-12% -$325K 0.45% 47
2017
Q1 		$2.73M Sell
40,133
-1,901
-5% -$134K 0.41% 51
2016
Q4 		$3.01M Sell
42,034
-5,379
-11% -$400K 0.47% 44
2016
Q3 		$3.75M Sell
47,413
-21,404
-31% -$1.74M 0.5% 42
2016
Q2 		$5.74M Buy
68,817
+5,936
+9% +$527K 0.71% 22
2016
Q1 		$5.78M Sell
62,881
-6,161
-9% -$556K 0.7% 24
2015
Q4 		$6.99M Buy
69,042
+1,023
+2% +$106K 0.72% 23
2015
Q3 		$6.68M Buy
68,019
+33,412
+97% +$3.71M 0.67% 19
2015
Q2 		$4.05M Sell
34,607
-5,044
-13% -$551K 0.35% 61
2015
Q1 		$3.89M Sell
39,651
-1,741
-4% -$177K 0.32% 73
2014
Q4 		$3.9M Buy
41,392
+821
+2% +$84.9K 0.32% 75
2014
Q3 		$4.32M Sell
40,571
-10,094
-20% -$988K 0.35% 66
2014
Q2 		$4.2M Sell
50,665
-2,928
-5% -$228K 0.34% 70
2014
Q1 		$3.8M Sell
53,593
-2,764
-5% -$217K 0.28% 86
2013
Q4 		$4.24M Buy
56,357
+7,680
+16% +$535K 0.33% 59
2013
Q3 		$3.06M Sell
48,677
-2,441
-5% -$146K 0.25% 96
2013
Q2 		$2.62M Buy
+51,118
New +$2.66M 0.22% 101

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Mercantile Trust's GILD Position: Q3 2021 in Review

First Mercantile Trust opened a new position in Gilead Sciences (GILD) in Q3 2021: 2,219 shares worth $155K. The stake represents 0.02% of the portfolio and ranks #501 among its holdings. This is a return to the name: First Mercantile Trust previously reported a position in GILD as recently as Q3 2020.

First Mercantile Trust first reported a position in GILD in Q2 2013 and has held it in 31 quarters since. The position peaked at $6.99M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • First Mercantile Trust held 2,219 shares of Gilead Sciences worth $155K as of Q3 2021.
  • Gilead Sciences was a new First Mercantile Trust position in Q3 2021.
  • Gilead Sciences made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #501 holding.
  • First Mercantile Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 31 quarters since.
  • First Mercantile Trust's Gilead Sciences position peaked at $6.99M in Q4 2015.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.